RxDoctor Payments Data

Alec Arturi, DO

Family Medicine · Monroe, INNPI 1063901551

Payments from drug & device makers

$436in general payments, 2019–2025

Across 25 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$114
  • Pfizer$50
  • Abbott$48
  • Exact Sciences$42
  • Sequel Med Tech, LLC$26
  • AbbVie$26
  • plus $130 from 7 others

What the payments were for

  • Food & beverage$41695%
  • Other$205%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$436 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$740
Medicare patients
62
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin102$151,820
OzempicSemaglutide87$150,581
MounjaroTirzepatide72$94,568
EliquisApixaban73$69,136
Trelegy ElliptaFluticasone/Umeclidin/Vilanter73$66,562
FarxigaDapagliflozin Propanediol63$63,389
Tresiba Flextouch U-200Insulin Degludec14$47,202
JanuviaSitagliptin Phosphate25$39,521
TrulicityDulaglutide20$34,019
XareltoRivaroxaban24$28,226
Spiriva HandihalerTiotropium Bromide24$27,170
Tresiba Flextouch U-100Insulin Degludec22$18,231
Incruse ElliptaUmeclidinium Bromide34$18,091
RybelsusSemaglutide11$17,690
Breo ElliptaFluticasone/Vilanterol32$14,538

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$20$168,27098 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$14$99,191139 claims
PfizerEliquis$50$69,13673 claims
AstraZenecaFarxiga$114$63,38963 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Monroe

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →